Commit To Buy Regulus Therapeutics At $7.50, Earn 31.4% Annualized Using Options
November 24, 2015 at 11:37 AM EST
Investors considering a purchase of Regulus Therapeutics Inc (RGLS) stock, but tentative about paying the going market price of $9.58/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2016 put at the $7.50 strike, which has a bid at the time of this writing of $1.15..